Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Hyperphagia 8Stomach Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Malnutrition 2Postoperative Complications 1Nutritional Support 1Nasopharyngeal Carcinoma 1Head and Neck Neoplasms 1Disease Progression 1Digestive System Neoplasms 1Deglutition Disorders 1

Interventions

Cisplatin 117Oxaliplatin 111Fluorouracil 100Capecitabine 90Docetaxel 69Leucovorin 60Irinotecan 57Paclitaxel 49S 1 (combination) 38pembrolizumab 35Trastuzumab 31Radiotherapy 25Bevacizumab 20Nivolumab 19Epirubicin 19titanium silicide 18Surgical Procedures, Operative 17Carboplatin 17Ramucirumab 16Cetuximab 15Gastrectomy 13apatinib 12Everolimus 12Gemcitabine 11Albumin-Bound Paclitaxel 10Neoadjuvant Therapy 8Folfox protocol 8Drug Therapy 8Chemotherapy, Adjuvant 8Radiation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Stomach Neoplasms × Parenteral Nutrition × Clear all
NCT07604857 2026-05-22

BRIDGE-GC

The Catholic University of Korea

Phase NA Completed
55 enrolled
Gastrointestinal

Hyperphagia, Stomach Neoplasms

NCT00558155 2007-11-14

The Impact of Immunostimulating Nutrition on the Outcome of Surgery

Jagiellonian University

Phase 4 Completed
214 enrolled
Gastrointestinal

Hyperphagia, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡